Editorial: Harnessing biomechanotransduction to influence cell fate. (2023)
Attributed to:
Developing the Nanokick Bioreactor for Commercialisation and Cell Therapy
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fbioe.2023.1357961
PubMed Identifier: 38249796
Publication URI: http://europepmc.org/abstract/MED/38249796
Type: Journal Article/Review
Volume: 11
Parent Publication: Frontiers in bioengineering and biotechnology
ISSN: 2296-4185